Loading the section…

PRCT: financial statements from SEC — TradeAlmanac

PRCT

PROCEPT BioRobotics Corporation: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	83M	83M	79M	69M	58M	53M
Cost of revenue	29M	29M	27M	25M	21M	22M
Gross profit	54M	54M	52M	44M	37M	31M
Research and development	21M	18M	18M	16M	17M	18M
Selling, general and administrative	65M	59M	56M	55M	43M	41M
Operating expenses	87M	77M	74M	72M	59M	58M
Operating income	−33M	−23M	−22M	−27M	−22M	−27M
Pre-tax income	−32M	—	—	−25M	—	—
Income tax	−43,000	—	—	−47,000	—	—
Net income	−32M	−21M	−20M	−25M	−21M	−26M
Earnings per share	−0.56	−0.38	−0.35	−0.45	−0.40	−0.50
Earnings per share, diluted	−0.56	−0.38	−0.35	−0.45	−0.40	−0.50
Weighted average shares	57M	56M	55M	55M	52M	52M
Weighted average shares, diluted	57M	56M	55M	55M	52M	52M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	246M	287M	294M	303M	316M	334M	197M	214M
Receivables	96M	84M	85M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−38M	−17M
Depreciation and amortisation	2M	1M
Share-based compensation	13M	10M
Capital expenditure	3M	2M
Investing cash flow	−3M	−2M
Financing cash flow	222,000

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator